Global and United States Anti-cancer Insurance Market Report & Forecast 2022-2028

Anti-cancer insurance is a kind of critical illness insurance, and anti-cancer medical insurance is a kind of medical insurance. The biggest difference is that it will be compensated once a diagnosis is made, and the other is that only medical expenses related to cancer are reimbursed. Compared with the anti-cancer medical insurance, the anti-cancer insurance has a longer-term and lasting protection, and the rate is constant, so there is no need to worry about renewal. Therefore, my answer to the senior sister focused on the analysis of cancer prevention insurance. The coverage of cancer prevention insurance is much smaller than that of critical illness insurance. It only targets malignant tumors, but it can also cover the highest incidence of serious illnesses.
Market Analysis and Insights: Global and United States Anti-cancer Insurance Market
This report focuses on global and United States Anti-cancer Insurance market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Anti-cancer Insurance market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Benefit-based Anti-cancer Insurance accounting for % of the Anti-cancer Insurance global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, People at the age of High Incidence of Cancer was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Anti-cancer Insurance market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Anti-cancer Insurance Scope and Market Size
Anti-cancer Insurance market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anti-cancer Insurance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Anti-cancer Insurance market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Benefit-based Anti-cancer Insurance
Reimbursable Anti-cancer Medical Insurance
Segment by Application
People at the age of High Incidence of Cancer
Middle-aged and Elderly Over 50 Years Old
People with a Family History of Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
ACE Insurance
Achmea
AEGON
Allianz
Anadolu Hayat Emeklilik
Assicurazioni Generali
Assurant
AIA Group
AlfaStrakhovanie
Banamex
Banco Bilbao Vizcaya Argentaria
Banco Bradesco
BNP Paribas Cardif
China Life Insurance Company
China Pacific Insurance
CNP Assurances
Credit Agricole
DZ Bank
Garanti Emeklilik ve Hayat
Great Eastern Holdings
Grupo Nacional Provincial
Hanwha Life Insurance Company
HDFC Standard Life Insurance Company
ICICI Prudential Life Insurance Company